Ebselen, a Selenium-based drug molecule, and several other novel compounds can change the characteristics of SOD1. The findings could help with the development of new therapeutics for ALS.
Treatment with copper-ATSM helped mouse models retain behavioral performance and prevented extensive motor neuron degeneration and microglial activation associated with ALS.
A new study claims researchers have been able to halt the progression of ALS for almost two years in mouse models of the disease.
A new study suggest specific protein instability as a cause of ALS.
New research would help emergency care workers and battlefield medics stabilize blood flow in the brains of traumatic injury victims. Researchers developed a nanoparticle-based antioxidant that quickly quenches free radicals that interfere with regulation of the brain’s vascular system.
